Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Reindl

Showing results (191-200 of 248) with videos related to

Pageof 25
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation|March 24, 2017
ADEM-like presentation, anti-MOG antibodies, and MS pathology: TWO case reportsPeter Körtvélyessy, Markus Breu, Marc Pawlitzki, et al.
Frontiers in Immunology|July 1, 2021
Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 PatientsEliott Lafon, Gabriel Diem, Christina Witting, et al.
Acta Neuropathologica|November 5, 2015
Highly encephalitogenic aquaporin 4-specific T cells and NMO-IgG jointly orchestrate lesion location and tissue damage in the CNSBleranda Zeka, Maria Hastermann, Sonja Hochmeister, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 31, 2015
MOG cell-based assay detects non-MS patients with inflammatory neurologic diseasePatrick Waters, Mark Woodhall, Kevin C O'Connor, et al.
Journal of Neuroinflammation|July 27, 2019
Optical coherence tomography in myelin-oligodendrocyte-glycoprotein antibody-seropositive patients: a longitudinal studyFrederike C Oertel, Olivier Outteryck, Benjamin Knier, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 8, 2009
Influence of interferon-beta therapy switching on neutralizing antibody titres: results from the Austrian Switch StudyClaudia Gneiss, Pia-Maria Koudouovoh-Tripp, Stefan Ropele, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 6, 2011
Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disordersSven Jarius, Christian Jacobi, Jerome de Seze, et al.
Journal of Neurology|May 6, 2016
Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopesMaria Sepúlveda, Thaís Armangue, Eugenia Martinez-Hernandez, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 18, 2025
A20 (TNFAIP3) Distinguishes Attack From Remission in Pediatric Patients With Monophasic MOGADChristian Lechner, Shrishti Saxena, Hrishikesh A Lokhande, et al.
Multiple Sclerosis and Related Disorders|December 15, 2024
Children with MOG-IgG positive bilateral optic neuritis misdiagnosed as fulminant idiopathic intracranial hypertensionEva-Maria Wendel, Daniel Tibussek, Nina Barisic, et al.
Pageof 25

Showing results (191-200 of 248) with videos related to

Sort By:
Pageof 25
Neurology(R) Neuroimmunology & Neuroinflammation|March 24, 2017
ADEM-like presentation, anti-MOG antibodies, and MS pathology: TWO case reportsPeter Körtvélyessy, Markus Breu, Marc Pawlitzki, et al.
Frontiers in Immunology|July 1, 2021
Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 PatientsEliott Lafon, Gabriel Diem, Christina Witting, et al.
Acta Neuropathologica|November 5, 2015
Highly encephalitogenic aquaporin 4-specific T cells and NMO-IgG jointly orchestrate lesion location and tissue damage in the CNSBleranda Zeka, Maria Hastermann, Sonja Hochmeister, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 31, 2015
MOG cell-based assay detects non-MS patients with inflammatory neurologic diseasePatrick Waters, Mark Woodhall, Kevin C O'Connor, et al.
Journal of Neuroinflammation|July 27, 2019
Optical coherence tomography in myelin-oligodendrocyte-glycoprotein antibody-seropositive patients: a longitudinal studyFrederike C Oertel, Olivier Outteryck, Benjamin Knier, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 8, 2009
Influence of interferon-beta therapy switching on neutralizing antibody titres: results from the Austrian Switch StudyClaudia Gneiss, Pia-Maria Koudouovoh-Tripp, Stefan Ropele, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 6, 2011
Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disordersSven Jarius, Christian Jacobi, Jerome de Seze, et al.
Journal of Neurology|May 6, 2016
Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopesMaria Sepúlveda, Thaís Armangue, Eugenia Martinez-Hernandez, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 18, 2025
A20 (TNFAIP3) Distinguishes Attack From Remission in Pediatric Patients With Monophasic MOGADChristian Lechner, Shrishti Saxena, Hrishikesh A Lokhande, et al.
Multiple Sclerosis and Related Disorders|December 15, 2024
Children with MOG-IgG positive bilateral optic neuritis misdiagnosed as fulminant idiopathic intracranial hypertensionEva-Maria Wendel, Daniel Tibussek, Nina Barisic, et al.
Pageof 25